BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Memento EPFL//
BEGIN:VEVENT
SUMMARY:EPFL BioE Talks SERIES  “Swissmedic Innovation Office - Bringing
  Innovation and Regulation Together“
DTSTART:20230925T160000
DTEND:20230925T170000
DTSTAMP:20260429T165930Z
UID:51aa925ef6ae20eb04d69574eebcec8e82f111b83e80ddad39487d0f
CATEGORIES:Conferences - Seminars
DESCRIPTION:Philippe Girard\, Ph.D.\, Vice-director and Head of licensing
 \, Swissmedic\, the Swiss Agency for Therapeutic Products\, Bern (CH)\nWEE
 KLY EPFL BIOE TALKS SERIES\n\nAbstract:\nBiomedical research is of central
  importance for Switzerland. For patients\, it is a matter of gaining acce
 ss as quickly as possible to medicines with a high unmet medical need\; fo
 r industry and the research sector\, it is a matter of creating the best p
 ossible framework conditions.\nAs a regulator\, Swissmedic has an importan
 t role to play here\, ensuring that only high-quality\, safe and effective
  medicines come onto the market in Switzerland and thus protecting patient
 s\, but it can also influence the regulatory environment and the way in wh
 ich researchers and industry work together. In this way\, Swissmedic can m
 ake research and the conditions for setting up advanced therapies for appr
 oval in Switzerland more attractive.\nNumerous new approaches and procedur
 es were used during the Covid-19 pandemic. Swissmedic wants to learn lesso
 ns from this\, and what has proved successful is to be transferred to regu
 lar operations. For example\, the exchange of information and advice was g
 reatly intensified during this period. In order to perpetuate this develop
 ment\, Swissmedic is planning to set up an Innovation Office to facilitate
  access to the Institute's regulatory\, scientific and technical knowledge
  and to promote exchange.\n\n\nBio:\nEducation:\n1998 – 2001 Doctoral st
 udies in Biotechnology\, EPFL\, Lausanne (CH)\; Ph.D.\n1995 – 1998 Chemi
 cal Engineering training at EPFL (Lausanne\, CH) and at the Iowa State Uni
 versity\, Ames\, IA (USA)\n\nPositions:\nSince Aug. 1\, 2022 Vice-directo
 r\, Swissmedic\, the Swiss Agency for Therapeutic Products\, Bern (CH)\n20
 19 – 2022 Director a.i.\, Swissmedic\, Bern (CH)\nSince 2015 Head of Aut
 horisations Dept.\, Swissmedic\, Bern (CH)\n2007 – 2015 Head of Laborato
 ry Dept. (Official Medicines Control Laboratory - OMCL)\, Swissmedic\, Ber
 n (CH)\n2004 – 2007 Product and Process Development Manager\, Debiopharm
  SA\, Lausanne (CH)\n2002 – 2004 CTO (Chief Technical Officer)\, ExcellG
 ene SA\, Monthey (CH)\n\n\nZoom link (with one-time registration for the w
 hole series) for attending remotely: https://go.epfl.ch/EPFLBioETalks\n\n\
 nInstructions for 1st-year Ph.D. students who are under EDBB’s mandatory
  seminar attendance rule:\nIF you are not attending in-person in the room\
 , please make sure to\n\n	send D. Reinhard a note before noon on seminar d
 ay\, informing that you plan to attend the talk online\, and\n	be signed i
 n on Zoom with a recognizable user name (not a pseudonym making it difficu
 lt or impossible to be identified).\n\nStudents attending the seminar in-p
 erson should collect a confirmation signature after the talk - please prin
 t your own signature sheet beforehand (71 kB pdf available for download he
 re).\n\n 
LOCATION:SV 1717 https://plan.epfl.ch/?room==SV%201717 https://go.epfl.ch/
 EPFLBioETalks
STATUS:CONFIRMED
END:VEVENT
END:VCALENDAR